Hale Elizabeth K
Ronald O. Perelman Department of Dermatology, New York University, USA.
Dermatol Online J. 2003 Oct;9(4):2.
Calciphylaxis is a rare, painful, and debilitating disease of widespread metastatic calcification that progresses to ischemic tissue necrosis. It occurs almost exclusively in patients with end-stage renal disease and secondary hyperparathyroidism. Reticulated, violaceous, mottled patches commonly appear on the lower extremities and progress to cordlike nodules and necrotic ulcers with overlying eschars. Septicemia, which may occur after secondary infection of the ulcers, is the most common cause of death. Treatment with phosphate-binding antacids, total or partial parathyroidectomy, and avoidance of local tissue trauma remain the mainstays of therapy, although a uniform cure for calciphylaxis remains elusive. Prognosis for patients with calciphylaxis is dismal, even after surgical intervention. Early diagnosis and treatment is critical to prevent progression of the disease process.
钙过敏是一种罕见、疼痛且使人衰弱的疾病,表现为广泛的转移性钙化,并进展为缺血性组织坏死。它几乎仅发生于终末期肾病和继发性甲状旁腺功能亢进的患者。网状、紫罗兰色、斑驳的斑块通常出现在下肢,并进展为条索状结节和伴有焦痂覆盖的坏死性溃疡。溃疡继发感染后可能发生的败血症是最常见的死亡原因。使用磷酸盐结合抗酸剂、甲状旁腺全切或部分切除术以及避免局部组织创伤仍然是主要的治疗方法,尽管目前仍难以找到治愈钙过敏的统一方法。即使经过手术干预,钙过敏患者的预后也很差。早期诊断和治疗对于预防疾病进展至关重要。